PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
Varenicline Tartrate Tablets | 0.5mg |
53 |
70748-127-49 |
Chantix® |
AB |
Smoking Cessation Aids |
|
Cyanocobalamin Nasal Spray | 500mcg/ spray |
4 UD |
43386-237-70 |
Nascobal® |
AB |
B12 Vitamins |
|
Ganirelix Acetate Injection | 250mcg/0.5mL |
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
|
Bromfenac Ophthalmic Solution 0.075% | 0.075% |
5ml |
68180-434-01 |
Bromsite® |
AT |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
|
Bromfenac Ophthalmic Solution 0.09% | 0.09% |
1.7mL |
68180-436-01 |
Bromday® |
AT2 |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
|
Doxycycline Capsules | 40mg |
30 |
70748-308-06 |
Oracea® |
AB |
Antibiotic |
|
Mirabegron Extended-Release Tablets | 25mg |
30 |
68180-151-06 |
Myrbetriq® |
AB |
Beta-3 Adrenergic Agonist |
|
Doxycycline for Injection USP | 100mg/ vial |
(10) single-dose vials |
70748-338-10 |
Vibramycin® |
AP |
Tetracycline Antibiotics |
|
GaviLyteâ„¢-N | 420-111.20-1.48-5.72 gm |
4 L |
43386-050-19 |
NuLYTELY® |
AA |
Hyperosmotic |
|
DOXOrubicin Hydrochloride Liposome Injection | 20mg/10mL (2mg/mL) |
(1) 10mL single-dose vial |
70748-339-01 |
Doxil® |
AB |
Chemotherapeutic Agents |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.